USD 23.15
(-1.53%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.14 USD | 84.44% |
2022 | -0.90 USD | -662.5% |
2021 | 0.16 USD | 114.29% |
2020 | -1.12 USD | -1541.44% |
2019 | 0.08 USD | -73.21% |
2018 | 0.29 USD | -94.41% |
2017 | 5.19 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.83 USD | -1614.88% |
2024 Q2 | -0.89 USD | -7.23% |
2024 Q3 | -0.02 USD | 31.46% |
2023 Q4 | -0.05 USD | -29.41% |
2023 FY | - USD | 84.44% |
2023 Q3 | -0.04 USD | 33.81% |
2023 Q2 | -0.06 USD | -18933.33% |
2023 Q1 | 0.00 USD | 100.03% |
2022 Q3 | 0.03 USD | 50.0% |
2022 Q2 | 0.02 USD | -71.43% |
2022 Q1 | 0.07 USD | 75.0% |
2022 FY | - USD | -662.5% |
2022 Q4 | -1.02 USD | -3500.0% |
2021 Q4 | 0.04 USD | -66.67% |
2021 Q3 | 0.12 USD | 267.6% |
2021 Q2 | -0.07 USD | -202.29% |
2021 Q1 | 0.07 USD | 108.54% |
2021 FY | - USD | 114.29% |
2020 Q1 | -0.02 USD | -121.89% |
2020 Q4 | -0.82 USD | -18.84% |
2020 Q3 | -0.69 USD | -392.86% |
2020 Q2 | -0.14 USD | -573.08% |
2020 FY | - USD | -1541.44% |
2019 Q3 | 0.04 USD | 243.33% |
2019 Q1 | -0.03 USD | 0.0% |
2019 FY | - USD | -73.21% |
2019 Q4 | 0.10 USD | 120.93% |
2019 Q2 | -0.03 USD | 0.0% |
2018 FY | - USD | -94.41% |
2017 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
American Well Corporation | -47.50 USD | 99.705% |
Doximity, Inc. | 0.78 USD | 117.949% |
Evolent Health, Inc. | -1.28 USD | 89.063% |
Phreesia, Inc. | -2.51 USD | 94.422% |
Teladoc Health, Inc. | -1.36 USD | 89.706% |
Veeva Systems Inc. | 3.27 USD | 104.281% |